| Anuh Pharma Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 506260 |
NSE Symbol : ANUHPHR |
P/E(TTM) : 21.39 |
|
ISIN Demat : INE489G01022 |
Div & Yield% : 0.91 |
EPS(TTM) : 3.86 |
|
Book Value(₹) : 32.62 |
Market Cap(₹Cr) : 827.35 |
Face Value(₹) : 5.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 185.88 | 186.48 | 198.14 | 159.51 | 165.95 | 137.91 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 185.88 | 186.48 | 198.14 | 159.51 | 165.95 | 137.91 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.98 | 3.39 | 1.40 | 0.94 | 3.40 | 3.72 |
| Total Income | 186.86 | 189.87 | 199.54 | 160.45 | 169.35 | 141.63 |
| Total Expenditure | 174.00 | 176.19 | 179.47 | 144.72 | 149.07 | 127.34 |
| PBIDT | 12.86 | 13.68 | 20.07 | 15.73 | 20.28 | 14.29 |
| Interest | 0.08 | 0.21 | 0.03 | 0.28 | 0.16 | 0.14 |
| PBDT | 12.78 | 13.47 | 20.04 | 15.45 | 20.12 | 14.15 |
| Depreciation | 2.86 | 2.52 | 2.76 | 2.18 | 1.92 | 1.88 |
| Tax | 2.80 | 2.49 | 5.42 | 3.18 | 3.99 | 2.72 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.49 | 0.16 | -0.59 | -0.26 | -0.84 | 0.04 |
| Reported Profit After Tax | 7.61 | 8.30 | 12.46 | 10.34 | 15.04 | 9.51 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 7.61 | 8.30 | 12.46 | 10.34 | 15.04 | 9.51 |
| EPS (Unit Curr.) | 0.76 | 1.66 | 2.49 | 2.06 | 3.00 | 1.90 |
| EPS (Adj) (Unit Curr.) | 0.76 | 0.83 | 1.25 | 1.03 | 1.50 | 0.95 |
| Calculated EPS (Unit Curr.) | 0.76 | 1.66 | 2.49 | 2.06 | 3.00 | 1.90 |
| Calculated EPS (Adj) (Unit Curr.) | 0.76 | 0.83 | 1.25 | 1.03 | 1.50 | 0.95 |
| Calculated EPS (Ann.) (Unit Curr.) | 3.04 | 6.63 | 9.94 | 8.26 | 12.01 | 7.59 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 3.04 | 3.32 | 4.97 | 4.13 | 6.01 | 3.80 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 50.11 | 25.06 | 25.06 | 25.06 | 25.06 | 25.06 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 6.92 | 7.34 | 10.13 | 9.86 | 12.22 | 10.36 |
| PBDTM(%) | 6.88 | 7.22 | 10.11 | 9.69 | 12.12 | 10.26 |
| PATM(%) | 4.09 | 4.45 | 6.29 | 6.48 | 9.06 | 6.90 |